Notably, evidence demonstrates that a reduced serum creatinine-to-cystatin C ratio (Cr/cysC) exhibits independent associations with both sarcopenia prevalence and elevated atherosclerotic plaque burden in type 2 diabetes populations (26). Here, CST3 is linked to sarcopenia.